BWA vs KPTI · P/E 41, rev $7.18B vs rev $68.5M
BorgWarner Inc (BWA) versus Karyopharm Therapeutics Inc (KPTI) — a side-by-side from cached financials, not a winner call.
BorgWarner Inc (BWA) is a auto parts company listed on NYSE.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Latest reported BWA revenue for 2026-06-30 was $7.18B. Net income was $519.0M. BWA currently screens at market cap $14.47B and trailing P/E 41.0.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
BWA currently screens at market cap $14.47B and trailing P/E 41.0. KPTI currently screens at market cap $205.6M.
Not investment advice. Open the BWA and KPTI stock pages for the full models.
Not investment advice.